Synthetic oxazolidinone antibiotic Indicated for treatment of bacterial pneumonia, skin and skin structure infections, and for vancomycin-resistant enterococcal (VRE) infections, including infections due to susceptible organisms which are complicated by bacteremia Inhibits MAO and may cause drug interactions with adrenergic and serotonergic drugs.

Composition

Each film coated tablet contains: Linezolid 400mg, 600mg. (As per Innovator’s Specs).

Indication

LINEZON is used; For the treatment of pneumonia, including community-acquired pneumonia and nosocomial pneumonia. For the treatment of skin and skin structure infections, including cellulitis and diabetic foot ulcer, due to susceptible organisms. For the treatment of sepsis or bacteremia due to vancomycin-resistant enterococci (VRE) or methicillin-resistant Staphylococcus aureus (MRSA). For the treatment of MRSA-associated bone and joint infections, including osteomyelitis and septic/infectious arthritis, or an orthopedic device-related infection. For the treatment of central nervous system infections, including meningitis, ventriculitis, brain abscess, subdural empyema, spinal epidural abscess, and septic thrombosis of the cavernous or dural venous sinus. For the treatment of febrile neutropenia. For the treatment of infective endocarditis. For the treatment of systemic anthrax infection.